These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 2291561
1. The development of hydroxypyridin-4-ones as orally active iron chelators. Hider RC, Singh S, Porter JB, Huehns ER. Ann N Y Acad Sci; 1990; 612():327-38. PubMed ID: 2291561 [No Abstract] [Full Text] [Related]
2. The design of orally active iron chelators. Hider RC, Zhou T. Ann N Y Acad Sci; 2005; 1054():141-54. PubMed ID: 16339660 [Abstract] [Full Text] [Related]
3. Influence of lipophilicity on the bioavailability and disposition of orally active 3-hydroxypyridin-4-one metal chelators. Yokel RA, Fredenburg AM, Meurer KA, Skinner TL. Drug Metab Dispos; 1995 Oct; 23(10):1178-80. PubMed ID: 8654208 [No Abstract] [Full Text] [Related]
4. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential. Liu ZD, Liu DY, Lu SL, Hider RC. J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215 [Abstract] [Full Text] [Related]
5. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential. Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Xiao G, van der Helm D. J Med Chem; 1993 Aug 20; 36(17):2448-58. PubMed ID: 8355246 [Abstract] [Full Text] [Related]
6. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values. Liu ZD, Piyamongkol S, Liu DY, Khodr HH, Lu SL, Hider RC. Bioorg Med Chem; 2001 Mar 20; 9(3):563-73. PubMed ID: 11310590 [Abstract] [Full Text] [Related]
7. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential. Liu ZD, Khodr HH, Lu SL, Hider RC. J Pharm Pharmacol; 2000 Mar 20; 52(3):263-72. PubMed ID: 10757413 [Abstract] [Full Text] [Related]
13. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents. Dehkordi LS, Liu ZD, Hider RC. Eur J Med Chem; 2008 May 20; 43(5):1035-47. PubMed ID: 17869385 [Abstract] [Full Text] [Related]
14. Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice. Smith AG, Clothier B, Francis JE, Gibbs AH, De Matteis F, Hider RC. Blood; 1997 Feb 01; 89(3):1045-51. PubMed ID: 9028337 [Abstract] [Full Text] [Related]
15. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice. Eybl V, Caisová D, Koutenský J, Kontoghiorghes GJ. Arch Toxicol Suppl; 1991 Feb 01; 14():185-7. PubMed ID: 1805729 [No Abstract] [Full Text] [Related]
16. The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values. Liu ZD, Piyamongkol S, Hider RC. Transfus Sci; 2000 Dec 01; 23(3):269-70. PubMed ID: 11099914 [No Abstract] [Full Text] [Related]
17. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant. Porter JB, Gyparaki M, Burke LC, Huehns ER, Sarpong P, Saez V, Hider RC. Blood; 1988 Nov 01; 72(5):1497-503. PubMed ID: 3179437 [Abstract] [Full Text] [Related]
18. Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice. Porter JB, Morgan J, Hoyes KP, Burke LC, Huehns ER, Hider RC. Blood; 1990 Dec 01; 76(11):2389-96. PubMed ID: 2257308 [Abstract] [Full Text] [Related]